The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data.

Liegl, Raffael G; Karcher, Helene; Chetty-Mhlanga, Shala; Igwe, Franklin; Freitas, Rita

Liegl, Raffael G; Karcher, Helene; Chetty-Mhlanga, Shala; Igwe, Franklin; Freitas, Rita.

Afiliación

Liegl RG; Department of Ophthalmology, University of Bonn, Ernst-Abbe-Straße 2, 53127, Bonn, Germany. Raffael.Liegl@ukbonn.de.
Karcher H; Novartis Pharma AG, Basel, Switzerland.
Chetty-Mhlanga S; IQVIA Real World Solutions, Basel, Switzerland.
Igwe F; Novartis Pharma AG, Basel, Switzerland.
Freitas R; Novartis Farma, Porto Salvo, Portugal.

Ophthalmol Ther ; 12(1): 195-208, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36327000

Palabras clave

Anti-VEGF injections; Brolucizumab; Clinical practice; Neovascular age-related macular degeneration (nAMD); Prolonged treatment intervals; REALIZE study; Real-world evidence; Reduced treatment burden; Treatment patterns

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies Idioma: En Revista: Ophthalmol Ther Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google